Patent ID: 8362060

Claim:
A crystalline hemiedisylate salt of 4′-{2-ethoxy-4-ethyl-5-[((S)-2-mercapto-4-methylpentanoylamino)methyl]imidazol-1-ylmethyl}-3′-fluorobiphenyl-2-carboxylic acid; wherein the crystalline hemiedisylate salt is selected from: form II, characterized by a powder x-ray diffraction pattern comprising diffraction peaks at 2θ values of 9.74±0.20, 11.00±0.20, 12.89±0.20, 14.27±0.20, 15.54±0.20, 18.62±0.20, and 23.78±0.20; and form I, characterized by a powder x-ray diffraction pattern comprising diffraction peaks at 2θ values of 9.89±0.20, 11.66±0.20, 13.55±0.20, 18.41±0.20, 20.42±0.20, and 22.46±0.20.